cor2ed
engage checkpoint medical linkedin twitter
bg

Pituitary Preceptorship: How do I decide when to discontinue cabergoline therapy in prolactinomas

Pituitary Preceptorship: How do I decide when to discontinue cabergoline therapy in prolactinomas

Dr. Greisa Vila

The educational content presented and discussed during the meeting are now available.
Portrait of Greisa Vila
Dr. Greisa Vila

Endocrinologist

Medical University of Vienna

Austria

preview next

time Expert View | open 15 min |accreditation: EACCME

download resources

I agree that this educational programme:

Was valuable to me:

1/3

This programme is supported by an Independent Educational Grant from Ipsen

Other programmes of interest

preview next